Display options
Cite
Gupta S, Haresh KP, Roy S, et al. Metabolic toxicities in patients undergoing treatment for nonhematological malignancy: A cross-sectional study. Indian J Med Paediatr Oncol. 2016;37(4):256-259doi: 10.4103/0971-5851.195737.
Gupta, S., Haresh, K. P., Roy, S., Kashyap, L., Adhikari, N., Pandey, R., Sharma, D., Julka, P. K., & Rath, G. K. (2016). Metabolic toxicities in patients undergoing treatment for nonhematological malignancy: A cross-sectional study. Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology, 37(4), 256-259. https://doi.org/10.4103/0971-5851.195737
Gupta, Subhash, et al. "Metabolic toxicities in patients undergoing treatment for nonhematological malignancy: A cross-sectional study." Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology vol. 37,4 (2016): 256-259. doi: https://doi.org/10.4103/0971-5851.195737
Gupta S, Haresh KP, Roy S, Kashyap L, Adhikari N, Pandey R, Sharma D, Julka PK, Rath GK. Metabolic toxicities in patients undergoing treatment for nonhematological malignancy: A cross-sectional study. Indian J Med Paediatr Oncol. 2016 Oct-Dec;37(4):256-259. doi: 10.4103/0971-5851.195737. PMID: 28144092; PMCID: PMC5234162.
Copy Download .nbib Format: NLM
Share it on

Indian J Med Paediatr Oncol. 2016 Oct-Dec;37(4):256-259. doi: 10.4103/0971-5851.195737.

Metabolic toxicities in patients undergoing treatment for nonhematological malignancy: A cross-sectional study.

Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology

Subhash Gupta, Kunhi Parambath Haresh, Soumyajit Roy, Lakhan Kashyap, Narayan Adhikari, Rambha Pandey, Dayanand Sharma, Pramod Kumar Julka, Goura Kishor Rath

Affiliations

  1. Department of Radiation Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.

PMID: 28144092 PMCID: PMC5234162 DOI: 10.4103/0971-5851.195737

Abstract

OBJECTIVES: The objective of this study was to evaluate the prevalence of metabolic toxicities in patients with different nonhematological malignancies admitted in oncology ward of a tertiary cancer care center while on treatment.

METHODS: We did this cross-sectional study over a period of 7 months (January-July 2013) for all adult patients (

RESULTS: A total of 46 events of metabolic toxicities were noted in 31 patients over this period. The most common of them was hyperglycemia (

CONCLUSION: Metabolic toxicities are common phenomena among cancer patients, especially those with young age, comorbidities, and having history of addictions. In young age, they might even be fatal, especially when they are treated with combined modality of treatment.

Keywords: Malignancies; metabolic toxicities; nonhematological

Conflict of interest statement

There are no conflicts of interest.

References

  1. J Clin Endocrinol Metab. 2008 Jun;93(6):2042-9 - PubMed
  2. Australas Med J. 2014 Jan 31;7(1):45-8 - PubMed
  3. Lancet Oncol. 2014 May;15(6):e205-12 - PubMed
  4. Med Oncol. 2012 Jun;29(2):1354-60 - PubMed
  5. J Cancer Res Ther. 2006 Jan-Mar;2(1):14-6 - PubMed
  6. Cancer. 2009 Oct 1;115(19):4636-44 - PubMed
  7. Asian Pac J Cancer Prev. 2014;15(8):3587-92 - PubMed
  8. N Engl J Med. 2013 Jun 20;368(25):2385-94 - PubMed
  9. Lancet Oncol. 2010 Jan;11(1):21-8 - PubMed
  10. Lancet Oncol. 2014 May;15(6):e223-33 - PubMed
  11. Cancer. 1987 Jul 1;60(1):1-4 - PubMed

Publication Types